Capital Access Group

Capital Access Group advises companies on effective engagement with investors. Our experienced team offers market-leading access with hard-to-reach investors, including smaller institutions, pension funds and private client fund managers. These under-serviced investors are located not only in London but across the regions of the UK and Europe. We have an unrivalled knowledge of this extensive audience, to whom our published research is distributed, as well as to larger institutions. We offer this service as part of an integrated investor communications strategy to promote a company’s investment story.

Our clients, ranging from AIM to FTSE 100 companies, benefit from our professional, long-term relationships with investors. Not only do we identify and target investors, we contact them directly and relay their views back to clients with analysis, interpretation and advice. This ensures that our clients are in control of their investor engagement. The objective is to improve the reach and engagement with investors, which in turn strengthens the share price.

Colin Smith
  • Colin Smith

Polarean Imaging | Updates: NIH & UVA Health sales, Ascend expansion

Since the interim results, Polarean has made three further announcements including the sale of a complete Xenon MRI system to the National Institutes of Health Clinical Center, a significant follow on sale to the University of Virginia and, most recently, an expansion of the Representative Agreement it signed with Ascend Imaging (Ascend) in June. Collectively, we believe the new sales secure Polarean's current revenue guidance of US$2.5m-US$3.5m for 2025 and bode well for future sales announceme...

Colin Smith
  • Colin Smith

AltynGold | Initiation – A golden opportunity

AltynGold is a gold miner in Kazakhstan where a recent 50% hike in processing capacity at its Sekisovskoye mine coupled with leverage to the rising gold price are transforming the company's financial outlook. Despite an exceptional share price performance, the valuation remains low on all measures suggesting very substantial upside remains. AltynGold has a large resource base with more than enough potential to reach its longer-term production target of 100Koz, 80% up on the newly established run...

Colin Smith
  • Colin Smith

Tullow Oil | Updates – reserves, Kenya disposal, CEO

Tullow has announced a number of key updates including the appointment of Ian Perks as CEO, completion of its Kenya disposal, and, most recently, a reserves update. As indicated at the interim results, Ghanaian reserves were revised down but we believe the negative adjustment of 7.3mmboe to Proven and Probable (2P) Reserves is likely less than the market feared and should be more than offset by conversion of 18.2mmboe of Contingent Resource into 2P Reserves once the Ghanaian licence extensions t...

Colin Smith
  • Colin Smith

Polarean Imaging | 1H25 results – Tough half but robust pipeline

Polarean had a tough first half to June as disruption to US healthcare funding resulted in no additional sales of the company's Xenon MRI systems during the half, notwithstanding a 650% YoY increase in the sales pipeline. The weakness in capital sales was only partially mitigated by a 36% increase in consumables revenue. Cash and net cash ended the half at US$7.3m and the company reiterated its cash runway through 2Q26. Full year revenue guidance was reduced to US$2.5m-US$3.5m (from US$5m-US$6m)...

Sarah Godfrey
  • Sarah Godfrey

BlackRock Energy & Resources Income | Remaining flexible amid a challe...

BlackRock Energy and Resources Income Trust (BERI) is already bouncing back from a challenging first half of FY25 (to 31 May), with NAV and share price total returns of c 19% in H225 to date. Portfolio managers Tom Holl (a mining expert) and Mark Hume (an energy specialist) have taken advantage of share price weakness in the energy transition space (largely sparked by fears over the anti-environmentalist agenda of the new US administration) to move to an overweight position in the segment for th...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch